412 related articles for article (PubMed ID: 33592059)
21. A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei.
Piliouras P; Ulett GC; Ashhurst-Smith C; Hirst RG; Norton RE
Int J Antimicrob Agents; 2002 May; 19(5):427-9. PubMed ID: 12007851
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility pattern of clinical isolates of Burkholderia pseudomallei in Bangladesh.
Dutta S; Haq S; Hasan MR; Haq JA
BMC Res Notes; 2017 Jul; 10(1):299. PubMed ID: 28728591
[TBL] [Abstract][Full Text] [Related]
23. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
[TBL] [Abstract][Full Text] [Related]
24. Expression of resistance-nodulation-cell-division efflux pumps in commonly used Burkholderia pseudomallei strains and clinical isolates from northern Australia.
Kumar A; Mayo M; Trunck LA; Cheng AC; Currie BJ; Schweizer HP
Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S145-51. PubMed ID: 19121677
[TBL] [Abstract][Full Text] [Related]
25. Unprecedented Melioidosis Cases in Northern Australia Caused by an Asian Burkholderia pseudomallei Strain Identified by Using Large-Scale Comparative Genomics.
Price EP; Sarovich DS; Smith EJ; MacHunter B; Harrington G; Theobald V; Hall CM; Hornstra HM; McRobb E; Podin Y; Mayo M; Sahl JW; Wagner DM; Keim P; Kaestli M; Currie BJ
Appl Environ Microbiol; 2016 Feb; 82(3):954-63. PubMed ID: 26607593
[TBL] [Abstract][Full Text] [Related]
26. Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptible to aminoglycosides and macrolides.
Podin Y; Sarovich DS; Price EP; Kaestli M; Mayo M; Hii K; Ngian H; Wong S; Wong I; Wong J; Mohan A; Ooi M; Fam T; Wong J; Tuanyok A; Keim P; Giffard PM; Currie BJ
Antimicrob Agents Chemother; 2014; 58(1):162-6. PubMed ID: 24145517
[TBL] [Abstract][Full Text] [Related]
27. Burkholderia pseudomallei resistance to antibiotics in biofilm-induced conditions is related to efflux pumps.
Sirijant N; Sermswan RW; Wongratanacheewin S
J Med Microbiol; 2016 Nov; 65(11):1296-1306. PubMed ID: 27702426
[TBL] [Abstract][Full Text] [Related]
28. Multilocus sequence types of clinical Burkholderia pseudomallei isolates from peninsular Malaysia and their associations with disease outcomes.
Zueter AR; Rahman ZA; Abumarzouq M; Harun A
BMC Infect Dis; 2018 Jan; 18(1):5. PubMed ID: 29291714
[TBL] [Abstract][Full Text] [Related]
29. In-vitro activity of β-lactams/trimethoprim-sulfamethoxazole combinations against different strains of Burkholderia pseudomallei.
Mohamad NI; Harun A; Hasan H; Deris ZZ
Trop Biomed; 2022 Mar; 39(1):11-16. PubMed ID: 35225295
[TBL] [Abstract][Full Text] [Related]
30. Genotypic and phenotypic relationship in Burkholderia pseudomallei indicates colonization with closely related isolates.
Radu S; Lihan S; Idris A; Ling OW; Al-Haddawi MH; Rusul G
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):760-3. PubMed ID: 10928372
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore.
Sivalingam SP; Sim SH; Aw LT; Ooi EE
J Antimicrob Chemother; 2006 Nov; 58(5):1102-3. PubMed ID: 16951412
[No Abstract] [Full Text] [Related]
32. Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei.
Webb JR; Price EP; Currie BJ; Sarovich DS
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348161
[TBL] [Abstract][Full Text] [Related]
33. Genetics and function of the capsules of Burkholderia pseudomallei and their potential as therapeutic targets.
Reckseidler-Zenteno SL; Moore R; Woods DE
Mini Rev Med Chem; 2009 Feb; 9(2):265-71. PubMed ID: 19200030
[TBL] [Abstract][Full Text] [Related]
34. Reduced susceptibility of Malaysian clinical isolates of Burkholderia pseudomallei to ciprofloxacin.
Liew FY; Tay ST; Puthucheary SD
Trop Biomed; 2011 Dec; 28(3):646-50. PubMed ID: 22433895
[TBL] [Abstract][Full Text] [Related]
35. Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance.
Sawasdidoln C; Taweechaisupapong S; Sermswan RW; Tattawasart U; Tungpradabkul S; Wongratanacheewin S
PLoS One; 2010 Feb; 5(2):e9196. PubMed ID: 20169199
[TBL] [Abstract][Full Text] [Related]
36. A case report of Tubo-ovarian abscess caused by Burkholderia pseudomallei.
Nernsai P; Sophonsritsuk A; Lertvikool S; Jinawath A; Chitasombat MN
BMC Infect Dis; 2018 Feb; 18(1):73. PubMed ID: 29422033
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic resistance in Burkholderia species.
Rhodes KA; Schweizer HP
Drug Resist Updat; 2016 Sep; 28():82-90. PubMed ID: 27620956
[TBL] [Abstract][Full Text] [Related]
38. Peptidyl-Prolyl Isomerase
Bzdyl NM; Scott NE; Norville IH; Scott AE; Atkins T; Pang S; Sarovich DS; Coombs G; Inglis TJJ; Kahler CM; Sarkar-Tyson M
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331957
[No Abstract] [Full Text] [Related]
39. Multi locus sequence typing of clinical Burkholderia pseudomallei isolates from Malaysia.
Arushothy R; Amran F; Samsuddin N; Ahmad N; Nathan S
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008979. PubMed ID: 33370273
[TBL] [Abstract][Full Text] [Related]
40. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei.
Wuthiekanun V; Cheng AC; Chierakul W; Amornchai P; Limmathurotsakul D; Chaowagul W; Simpson AJ; Short JM; Wongsuvan G; Maharjan B; White NJ; Peacock SJ
J Antimicrob Chemother; 2005 Jun; 55(6):1029-31. PubMed ID: 15886263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
